On the afternoon of April 6, GENTIS company held a conference to report on the topic "Update new information on male testing and FSH test to support ovarian stimulation treatment" at the Hospital of Andrology. Infertility Vietnam Belgium.
The seminar had the participation of more than 20 doctors and nurses from the leadership, department heads, doctors and nurses working at the Hospital, especially in the presence of Dr. BS. Le Thi Hieu - Deputy Director of the Hospital, Dr. Ha Ngoc Manh - Deputy Director of the Hospital, cum Head of the Department of Andrology.
At the exchange, BSNT. Nguyen Thi Huyen - GENTIS geneticist gave a detailed report on current gynecological tests and the latest updates at GENTIS for the Hospital side.
Through the report, the hospital's doctors had a better overview of the test indications for male patients to contribute to determining the cause of infertility, diagnosing and treating male infertility effectively. Some tests are still used for male gynecology such as: Semen map, Karyotype, AZF, sperm DNA fragmentation, CFTR... have been performed by Viet Belgium Hospital.
In addition, the GENTIS geneticist also pointed out the improvements, superiority and high quality in male testing at GENTIS that will optimally support doctors in male infertility treatment regimens.
In addition to the report on the laboratory tests, Dr. Nguyen Van Quang - GENTIS Product Manager shared about the FSH receptor gene polymorphism test, a new test developed by GENTIS to assist doctors in the process. ovarian stimulation.
The FSH receptor gene polymorphism test is a test that allows the identification of genetic variants associated with the response to ovarian stimulation. With this test, the doctor will come up with an optimal and personalized ovarian stimulation regimen for each patient. Also aids in determining the cause of poor ovarian response (POR) or in the evaluation of high-risk cases of ovarian hyperstimulation.
According to Drs. Quang, GENTIS is the first unit in the North to deploy FSH receptor gene polymorphism test and perform on 4 SNPs proven to be associated with poor ovarian response (rs6165, rs6166, rs1394205, rs10835638) .
GENTIS' FSH test report attracted the attention of many doctors at the conference. Doctor Ha Ngoc Manh (Deputy Director of the Hospital) questioned the FSH test with the recommendations for the use of drugs after the FSH test for patients with poor response to ovarian stimulation and the studies clinical research in Vietnam. This is also the goal GENTIS is conducting research on this test in Vietnam for the poor responder group to have the best comparison for doctors when ordering the test.
BS. Le Thi Hieu (Deputy Director of the Hospital) is also very interested in this test and hopes that GENTIS will research and provide the closest indication thresholds, in order to support doctors in ovarian stimulation treatment regimens. Dr. Hieu said that in the coming time, Viet Belgium Hospital will also offer plans to support GENTIS in research on FSH testing.
After the discussion, GENTIS and the Vietnam - Belgium Hospital of Andrology & Infertility have come up with many useful cooperation proposals to apply high-tech tests in clinical practice, helping infertility treatment cases more effective to saving time and costs.
Once again, congratulations on the successful seminar and will continue to deploy more useful exchanges to hospitals across the country.